Additionally, by upregulating Nurr1 and tyrosine hydroxylase (TH) and downregulating α-synuclein, NF-κB inhibition may reduce the manufacturing of inflammatory factors, thereby alleviating the inflammation in PD [101]. This evidence concerns the gene SNCA and Parkinson disease.